UNITED STATES SECURITIES AND EXCHANGE COMMISSION

                      WASHINGTON, DC  20549


                            FORM 10-Q

   (MARK ONE) QUARTERLY REPORT / X / OR TRANSITION REPORT /  /
               PURSUANT TO SECTION 13 OR 15(d) OF
               THE SECURITIES EXCHANGE ACT OF 1934



For the quarter ended
July 31, 1999                          Commission File No. 1-5865



                     GERBER SCIENTIFIC, INC.
                ---------------------------------
                   (Exact name of Registrant as
                    specified in its charter)



           CONNECTICUT                             06-0640743
 -------------------------------              ---------------------
 (State or other jurisdiction of                  (IRS Employer
  incorporation or organization)               Identification No.)


 83 Gerber Road West, South Windsor, Connecticut       06074
------------------------------------------------- ---------------
    (Address of principal executive offices)         (Zip Code)



Registrant's Telephone Number, including area      (860) 644-1551
code                                              ---------------


Indicate  by check mark whether the registrant (1) has filed  all
reports  required  to be filed by Section  13  or  15(d)  of  the
Securities  Exchange Act of 1934 during the preceding  12  months
(or  for such shorter period that the registrant was required  to
file  such  reports)  and  (2) has been subject  to  such  filing
requirements for the past 90 days.


                     Yes  / X / .   No /    /.

At July 31, 1999, 22,173,235 shares of common stock of the
Registrant were outstanding.

<PAGE 1>

                     GERBER SCIENTIFIC, INC.
                        AND SUBSIDIARIES
            CONTENTS OF QUARTERLY REPORT ON FORM 10-Q

                   Quarter Ended July 31, 1999


                                                             PAGE



Part I - Financial Information

  Item 1. Consolidated Financial Statements:

           Statements of Earnings for the three months
           ended July 31, 1999 and 1998                      2

           Balance Sheets at July 31, 1999 and
           April 30, 1999                                  3-4

           Statements of Cash Flows for the three months
           ended July 31, 1999 and 1998                      5

           Notes to Financial Statements                     6

           Independent Accountants' Report                  10

  Item 2. Management's Discussion and Analysis of
           Financial Condition and Results of Operations    11


Part II - Other Information

  Item 6.  Exhibits and Reports on Form 8-K                 18


Signature                                                   19

Exhibit Index                                               20

<PAGE 2>

PART I - FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
               CONSOLIDATED STATEMENTS OF EARNINGS

--------------------------------------------------------------
                                             Three Months
In thousands (except per share amounts)     Ended July 31,
--------------------------------------------------------------
                                           1999       1998
                                        ----------------------
Revenue:

  Product sales                         $125,856     $142,166
  Service                                 13,620       11,493
                                        --------     --------
                                         139,476      153,659
                                        --------     --------

Costs and Expenses:

  Cost of product sales                   72,621       83,868
  Cost of service                          7,305        6,687
  Selling, general and administrative     37,228       41,756
  Research and development expenses        8,598        7,628
                                        --------     --------
                                         125,752      139,939
                                        --------     --------

Operating income                          13,724       13,720

Other income                                 393          260
Interest expense                          (2,464)      (3,158)
                                        --------     --------

Earnings before income taxes              11,653       10,822

Provision for income taxes                 4,100        4,100
                                        --------     --------

Net earnings                            $  7,553     $  6,722
                                        ========     ========
Per share of common stock:
  Basic                                 $    .34     $    .30
  Diluted                               $    .34     $    .29

  Dividends                             $    .08     $    .08

Average shares outstanding:
  Basic                                   22,118       22,673
  Diluted                                 22,452       23,514

                     See Accompanying Notes

<PAGE 3-4>

             GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                   CONSOLIDATED BALANCE SHEETS


---------------------------------------------------------------
                                          July 31,   April 30,
In thousands                               1999         1999
---------------------------------------------------------------
Assets
Current Assets:
 Cash and short-term cash investments     $ 17,486     $ 26,523
 Accounts receivable                       108,388      103,118
 Inventories                                82,866       72,367
 Prepaid expenses                           17,125       23,690
                                          --------     --------
                                           225,865      225,698
                                          --------     --------
Property, Plant and Equipment              156,810      152,374
 Less accumulated depreciation              64,909       61,789
                                          --------     --------
                                            91,901       90,585
                                          --------     --------

Intangible Assets                          239,229      238,777
 Less accumulated amortization              20,388       18,018
                                          --------     --------
                                           218,841      220,759
                                          --------     --------
Other Assets                                 4,785        5,218
                                          --------     --------
                                          $541,392     $542,260
                                          ========     ========
Liabilities and Shareholders' Equity

Current Liabilities:
 Current maturities of long-term debt     $     --     $    193
 Accounts payable                           46,182       48,374
 Accrued compensation and benefits          16,160       18,982
 Other accrued liabilities                  32,177       35,854
 Deferred revenue                            7,755        6,874
 Advances on sales contracts                 6,464        5,721
                                          --------     --------
                                           108,738      115,998
                                          --------     --------
Noncurrent Liabilities:
 Deferred income taxes                       9,842        9,593
 Long-term debt                            172,195      173,338
                                          --------     --------
                                           182,037      182,931
                                          --------     --------

Contingencies and Commitments

Shareholders' Equity:
 Preferred stock, no par value;
  authorized 10,000,000 shares; no
  shares issued                                 --           --
 Common stock, $1.00 par value;
  authorized 65,000,000 shares; issued
  22,973,235 and 22,858,699 shares          22,973       22,859
 Paid-in capital                            42,345       40,255
 Retained earnings                         201,632      195,871
 Treasury stock, at cost (800,000
  shares)                                  (16,450)     (16,450)
 Unamortized value of restricted stock
  grants                                      (531)        (417)
 Accumulated other comprehensive income        648        1,213
                                          --------     --------
                                           250,617      243,331
                                          --------     --------
                                          $541,392     $542,260
                                          ========     ========


                     See Accompanying Notes
<PAGE 5>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
              CONSOLIDATED STATEMENTS OF CASH FLOWS
---------------------------------------------------------------------
                                                      Three Months
In thousands                                         Ended July 31,
---------------------------------------------------------------------
                                                  1999         1998
                                               ----------------------
Cash Provided by (Used for):
Operating Activities:
  Net earnings                                  $  7,553     $  6,722
  Adjustments to reconcile net earnings to
   cash provided by operating activities:
     Depreciation and amortization                 6,096        5,662
     Deferred income taxes                           249         (591)
     Other non-cash items                             76           41
     Changes in operating accounts, net of
      effects of business acquisitions:
      Receivables                                 (5,270)      (5,106)
      Inventories                                (10,499)       4,355
      Prepaid expenses                             6,565       10,918
      Accounts payable and accrued expenses       (6,845)      (6,004)
                                                --------     --------
Provided by (Used for) Operating Activities       (2,075)      15,997
                                                --------     --------
Investing Activities:
  Additions to property, plant and equipment      (5,069)      (2,465)
  Business acquisitions                               --     (175,923)
  Intangible and other assets                          8         (129)
  Other, net                                         590          610
                                                --------     --------
(Used for) Investing Activities                   (4,471)    (177,907)
                                                --------     --------
Financing Activities:
  Additions of long-term debt                     10,606      181,686
  Repayments of long-term debt                   (13,097)      (7,383)
  Net short-term financing                            --      (11,585)
  Debt issue costs                                    --         (705)
  Proceeds from issuance of stock                  1,765        1,051
  Dividends on common stock                       (1,765)      (1,811)
                                                --------     --------
Provided by (Used for) Financing Activities       (2,491)     161,253
                                                --------     --------

(Decrease) in Cash and Short-Term
  Cash Investments                                (9,037)        (657)

Cash and Short-Term Cash Investments,
  Beginning of Period                             26,523       27,007
                                                --------     --------

Cash and Short-Term Cash Investments,           $ 17,486     $ 26,350
  End of Period                                 ========     ========
                     See Accompanying Notes

<PAGE 6>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
     NOTES TO (UNAUDITED) CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1. Basis of Presentation

The accompanying unaudited consolidated financial statements have
been  prepared  in accordance with generally accepted  accounting
principles  for  interim  financial  statements  and   with   the
instructions  to  Form  10-Q and Article 10  of  Regulation  S-X.
Accordingly,  they  do  not include all of  the  information  and
footnotes  required  by generally accepted accounting  principles
for complete financial statements.  In the opinion of management,
all   adjustments  (consisting  of  normal  recurring   accruals)
considered necessary for a fair presentation have been  included.
Operating results for the three-month period ended July 31,  1999
are  not  necessarily  indicative of  the  results  that  may  be
expected for the year ended April 30, 2000.

For  further  information,  refer to the  consolidated  financial
statements and footnotes thereto included in the Company's Annual
Report on Form 10-K for the year ended April 30, 1999.

NOTE 2. Inventories

The classification of inventories was as follows (in thousands):

                                  July 31, 1999  April 30, 1999
                                  -------------  --------------
Raw materials and purchased          $49,411         $42,097
 parts
Work in process                       33,455          30,270
                                     -------         -------
                                     $82,866         $72,367
                                     =======         =======

NOTE 3. Segment Information
                                         Three Months Ended
In thousands                                  July 31,
--------------------------------    ----------------------------
                                        1999            1998
                                    -------------   -------------
Segment revenue:
 Sign Making & Specialty Graphics        $ 68,334        $ 72,559
 Apparel & Flexible Materials              48,865          53,268
 Ophthalmic Lens Processing                22,277          27,832
                                         --------        --------
                                         $139,476        $153,659
                                         ========        ========
Segment profit:
 Sign Making & Specialty Graphics        $  8,866        $  9,080
 Apparel & Flexible Materials               5,144           5,521
 Ophthalmic Lens Processing                 1,251           1,659
                                         --------        --------
                                         $ 15,261        $ 16,260
                                         ========        ========
<PAGE 7>

A  reconciliation  of  total  segment  profits  to  consolidated
earnings before income taxes is as follows:

                                         Three Months Ended
In thousands                                  July 31,
--------------------------------     ---------------------------
                                         1999           1998
                                      ------------  ------------
Segment profit                            $ 15,261      $ 16,260
Corporate expenses, net of
 other income/expense                       (1,144)       (2,280)
                                          --------      --------
Earnings before interest and taxes          14,117        13,980
Interest expense                            (2,464)       (3,158)
                                          --------      --------
Earnings before income taxes              $ 11,653      $ 10,822
                                          ========      ========

There  were no material changes in segment assets or differences
in  the  basis of segmentation since the Company's  last  Annual
Report on Form 10-K.  However, the measure of segment profit was
changed.  In the Company's segment disclosures on Form 10-K for
the year ended April 30, 1999, and allocation of general corporate
expenses was included in the measure of segment profit.  For the
three-month  periods ended July 31, 1999 and 1998, segment profit
is reported as earnings before interest, taxes, and general corporate
expenses.

NOTE 4. Comprehensive Income

The  Company's  total comprehensive income  was  as  follows  (in
thousands):
                                             Three Months Ended
                                                  July 31,
                                             ------------------
                                              1999      1998
                                             --------  --------
Net income                                     $7,553    $6,722
Other comprehensive income (loss):
  Foreign currency translation adjustments      (565)       610
                                               ------    ------
  Total comprehensive income                   $6,988    $7,332
                                               ======    ======

<PAGE 8>

NOTE 5. Earnings Per Share

The  following  table  sets forth the computation  of  basic  and
diluted earnings per share for the periods indicated:

                                    Three Months Ended
                                         July 31,
                                  ------------------------
                                     1999         1998
                                  ----------    ----------
Numerator:
 Net Income                      $ 7,553,000   $ 6,722,000
                                 ===========   ===========
Denominators:
 Denominator for basic earnings
  per share--weighted-average
  shares outstanding              22,118,027    22,673,074
 Effect of dilutive
  securities:
  Employee stock options             333,782       840,977
                                 -----------   -----------
  Denominator for diluted
   earnings per share-
   adjusted weighted-average
   shares outstanding             22,451,809    23,514,051
                                 ===========   ===========
Basic earnings per share         $       .34   $       .30
                                 ===========   ===========
Diluted earnings per share       $       .34   $       .29
                                 ===========   ===========


<PAGE 9>


GERBER SCIENTIFIC, INC. AND SUBSIDIARIES

With  respect to the unaudited consolidated financial  statements
of  Gerber Scientific, Inc. and subsidiaries at July 31, 1999 and
for  the  three-month periods ended July 31, 1999 and 1998,  KPMG
LLP  has  made  a  review  (based on procedures  adopted  by  the
American  Institute of Certified Public Accountants) and  not  an
audit,  as  set forth in their separate report dated  August  18,
1999  appearing  on  page 10.  That report does  not  express  an
opinion   on   the   interim  unaudited  consolidated   financial
information.   KPMG  LLP has not carried out any  significant  or
additional  audit  tests  beyond  those  which  would  have  been
necessary  if  their report had not been included.   Accordingly,
such  report  is  not  a "report" or "part  of  the  Registration
Statement"  within  the  meaning of Sections  7  and  11  of  the
Securities Act of 1933 and the liability provisions of Section 11
of such Act do not apply.


<PAGE 10>


                 INDEPENDENT ACCOUNTANTS' REPORT


To the Board of Directors and Shareholders of
Gerber Scientific, Inc.


We  have made a review of the consolidated statements of earnings
and  cash  flows of Gerber Scientific, Inc. and subsidiaries  for
the  three-month  periods ended July 31, 1999 and  1998  and  the
consolidated balance sheet as of July 31, 1999 in accordance with
standards  established  by the American  Institute  of  Certified
Public  Accountants.  We have previously audited,  in  accordance
with  generally  accepted auditing standards, and  expressed  our
unqualified  opinion  dated  May 26,  1999  on  the  consolidated
financial  statements  for the year ended  April  30,  1999  (not
presented  herein).  The aforementioned financial statements  are
the responsibility of the Company's management.

A review of interim financial information consists principally of
applying  analytical  review procedures  to  financial  data  and
making  inquiries  of  persons  responsible  for  financial   and
accounting  matters.  It is substantially less in scope  than  an
examination  in  accordance  with  generally  accepted   auditing
standards, the objective of which is the expression of an opinion
regarding   the   financial  statements   taken   as   a   whole.
Accordingly, we do not express such an opinion.

Based   on   our  review,  we  are  not  aware  of  any  material
modifications   that   should  be  made   to   the   accompanying
consolidated statements of earnings and cash flows for the three-
month  periods  ended July 31, 1999 and 1998 or the  consolidated
balance  sheet  as of July 31, 1999 for them to be in  conformity
with  generally  accepted  accounting principles.  Also,  in  our
opinion  the information in the accompanying consolidated balance
sheet  as  of April 30, 1999 is fairly presented, in all material
respects,  in  relation to the consolidated  balance  sheet  from
which it has been derived.




/s/ KPMG LLP


Hartford, Connecticut
August 18, 1999


<PAGE 11>


ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS

OVERVIEW

Sales  for  the  first quarter ended July 31,  1999  were  $139.5
million,  a  decrease of 9.2 percent from the  same  period  last
year.  The predominant causes of the decrease were lower revenues
in  the  Company's Ophthalmic Lens Processing operating  segment,
the  sale  of certain distribution operations in the Sign  Making
and  Specialty  Graphics operating segment in last year's  second
quarter,  and relatively weaker European currencies.  Sales  were
also adversely affected by the first quarter implementation of  a
new  enterprise resource planning (ERP) system for the  Company's
Apparel and Flexible Materials operating segment.

The  Company's  backlog grew significantly in this  year's  first
quarter  to $63.9 million at July 31, 1999, an increase of  $17.4
million  from the prior year comparable period and $13.1  million
higher  than at the beginning of the current fiscal  year.   This
growth   was  caused  by  a  higher  level  of  orders  received,
particularly for products recently introduced, and by  the  lower
first quarter shipments.

Operating  income for the first quarter ended July  31,  1999  of
$13.7  million  was  substantially the same  as  the  prior  year
comparable  period.   Higher  gross  profit  margins  and   lower
selling,  general and administrative (S,G,&A) expenses this  year
overcame the comparative sales shortfall.  The Company's gross profit  margin
percentage of 42.7 percent in this year's first quarter  was  1.6
percentage  points higher than the prior year margin of 41.1  percent.
This  was  caused  by  a current year sales mix  favoring  higher
margin products as well as higher levels of service revenue.  The
effect  of acquisition synergies and this year's lower  level  of
sales  were principal reasons for the lower S,G,&A spending, along
with  actions  taken  to  resize the Ophthalmic  Lens  Processing
operating  segment  in last year's fourth  quarter.   The  higher
level of research and development (R&D) expenses incurred in this
year's  first quarter was associated with the strong new  product
flow.

Lower  interest expense and a lower tax rate caused net  earnings
to  rise  for the three month period ended July 31, 1999 compared
with  the  same  period  last year. Diluted  earnings  per  share
increased  17 percent to $0.34 in this year's first quarter  from
$0.29 per share for the same period last year.

The  Company's  cash flow was adversely affected in  this  year's
first quarter by growth in working capital.  This growth  was
related  to  increased inventory associated with the introduction
of  new  products and inventory and receivable build-ups related
to the ERP system implementation noted above.


<PAGE 12>


FINANCIAL CONDITION

The  Company's ratio of current assets to current liabilities was
2.1  to  1  at July 31, 1999 compared with 1.9 to 1 at April  30,
1999.   Net working capital at July 31, 1999 was $117.1  million,
an  increase  of $7.4 million from the beginning of  the  current
fiscal  year and largely attributable to higher inventory  levels
resulting  from  new product introductions and ERP implementation
issues  that  adversely  affected  both  inventory  and  accounts
receivable balances.

The  Company's  cash  and investments totaled  $17.5  million  at
July 31, 1999 compared with $26.5 million at the end of the prior
fiscal year.  Operating activities used $2.1 million in cash  for
the  three-month period ended July 31, 1999 compared  with  $16.0
million provided by operating activities for the same period last
year.  Cash  generated by earnings and the non-cash  charges  for
depreciation  and amortization in this year's first three  months
was  offset by higher accounts receivable and inventory balances.
Lower  accounts  payable  and accrued liabilities  balances,  due
largely  to the timing of payments, also contributed to the  cash
usage in the first quarter.

The principal non-operating use of cash in the three months ended
July 31, 1999 was for additions to property, plant, and equipment
of   $5.1   million.   The  Company  anticipates   that   capital
expenditures for the current fiscal year will be in the range  of
$22 - $25 million and expects to fund these with cash on hand and
cash  from  operations.   Cash  was  also  used  for  payment  of
dividends of $1.8 million in the first quarter.

The  Company's total long-term debt at July 31, 1999  was  $172.2
million, down slightly from the April 30, 1999 balance of  $173.5
million.  Net  debt  (total debt less cash and  investments)  was
$154.7  million at July 31, 1999 versus $147.0 million  at  April
30,  1999,  as cash was used in the first quarter to finance  the
growth in inventories and accounts receivable.  The ratio of  net
debt  to total capital increased slightly to 38.2 percent at July
31, 1999 from 37.7 percent at April 30, 1999.

RESULTS OF OPERATIONS

Combined  sales  and  service revenue for the three-month  period
ended  July 31, 1999 was $139.5 million, which was $14.2  million
(9.2  percent)  lower  than the first  quarter  last  year.   The
decrease  reflected  lower  product  sales  and  higher   service
revenue.   The lower product sales were caused by lower shipments
of Ophthalmic Lens Processing equipment ($5.6 million), which had
been  anticipated;  the prior year sale of  certain  distribution
operations  in  the Sign Making and Specialty Graphics  operating
segment  ($2.5  million); and the impact on sales  of  relatively
weaker  European  currencies ($2.5  million).   Sales  were  also
adversely affected by the first quarter ERP implementation
in the Apparel and Flexible Materials operating segment.  Service

<PAGE 13>

revenue  increased  $2.1  million (18.5  percent).   The  largest
increase  came from the Apparel and Flexible Materials  operating
segment  and was partly the result of incentives used to  enhance
that segment's service business.

The  consolidated gross profit margin in this year's first  three
months was 42.7 percent, which was significantly higher than  the
prior year margin of 41.1 percent.  Gross profit margins on  both
product  sales and service were higher.  The increase in  product
gross  profit  margins was the result of a product  mix  favoring
higher  margin  products such as software in  the  Apparel  and
Flexible  Materials  operating segment and  newly  introduced
digital  imaging  products  in  the  Sign  Making  and  Specialty
Graphics operating segment.  The increase in service gross profit
margins  related  to the Apparel and Flexible Materials  business
and was caused by the service revenue increase noted above.

S,G,&A  expenses  decreased $4.5 million (10.8  percent)  in  the
first  quarter compared with the prior year. In addition  to  the
lower  spending  related to the lower revenue base,  the  Company
realized  marketing  synergies in the Sign Making  and  Specialty
Graphics operating segment through the acquisition of Spandex PLC
and  in  the Ophthalmic Lens Processing operating segment through
the  acquisition  of Coburn Optical Industries, Inc.  The  S,G,&A
reduction  was also partly the result of management action  taken
in  the  prior  year  to  resize the Ophthalmic  Lens  Processing
operating  segment.   As a percentage of sales,  S,G,&A  expenses
decreased to 26.7 percent in this year's first quarter from  27.2
percent last year.

The Company continued to commit significant resources to research
and  the  development  of  new products. R&D  spending  increased
$1 million (12.7 percent) in the first quarter compared with last
year's first quarter.  The increase was related to the stepped-up
flow  of  new  products  from  each of  the  Company's  operating
segments.  As a percentage of sales, research and development was
6.2  percent in the first quarter compared with 5.0 percent  last
year.  In addition to the higher spending, the lower revenue base
in   this   year's  first  quarter  contributed  to  the   higher
percentage.

<PAGE 14>

Interest  expense decreased $0.7 million to $2.5 million  in  the
first  quarter ended July 31, 1999, the result of lower  interest
rates  and lower debt balances.  Most of the Company's borrowings
were  against  a  $235  million multi-currency  revolving  credit
facility. The interest rate on these borrowings is based  on  the
London  Interbank Offered Rate (LIBOR) for the relevant  currency
and term plus a margin based on the relationship of the Company's
consolidated  total  debt  to EBITDA (earnings  before  interest,
taxes, depreciation, and amortization).

The  provision  rate for income taxes was 35.2  percent  for  the
three  months ended July 31, 1999 compared with 37.9  percent  in
the  comparable prior year period and 35.8 percent for  the  full
prior  fiscal  year.  The lower tax rate this year was  primarily
the  result  of tax reduction strategies involving the  Company's
wholly-owned foreign subsidiaries.

As  a  result of the above, net earnings increased in this year's
first  quarter to $7.6 million or $.34 diluted earnings per share
from  $6.7  million or $.29 diluted earnings per  share  in  last
year's first quarter.

NEW ACCOUNTING PRONOUNCEMENT

In  June  1998, the Financial Accounting Standards  Board  (FASB)
issued  Statement No. 133, "Accounting for Derivative Instruments
and  Hedging  Activities" (SFAS 133).  The Statement  establishes
accounting  and  reporting  standards requiring  that  derivative
instruments be recorded in the balance sheet as either  an  asset
or  liability  measured at fair value and that  changes  in  fair
value  be recognized currently in earnings, unless specific hedge
accounting  criteria  are met.  In June  1999,  the  FASB  issued
Statement  No.  137, "Accounting for Derivative  Instruments  and
Hedging  Activities  -  Deferral of the Effective  Date  of  FASB
Statement  No. 133," which delays the required adoption  of  SFAS
133  to  the Company's fiscal year 2002.  The timing of  adoption
and the effect of SFAS 133 on the Company's financial position or
results of operations have not yet been determined.

YEAR 2000

As  disclosed in the Company's Annual Report on Form 10-K for the
year  ended  April 30, 1999, the Company recognizes the  business
risks  posed by the Year 2000 date issue and is actively  working
to  control  the associated risks.  The risks identified  by  the
Company's  Year 2000 compliance program remain the same  and  the
Company's  assessment  and remediation  plans  have  not  changed
materially  in  terms of scope, timing, or estimated  costs.   The
Company  has  completed its Year 2000 awareness, assessment,  and
renovation   phases,   and   has  substantially   completed   the
verification and validation phase.


<PAGE 15>

The  Company  believes its mission critical internal  information
technology (IT) systems and non-IT systems are ready for the Year
2000.   Contingency plans are being developed,  particularly  for
high risk areas such as those involving supplier management.

The  Company  has  assessed  its  Year  2000  risks  related   to
significant   relationships  with  third  parties   via   ongoing
communication  with  its critical suppliers and  customers.   The
Company  continues  to  monitor and work directly  with  its  key
suppliers  and  customers  to avoid any  business  interruptions.
Despite these efforts, the Company can provide no assurance  that
supplier  and  customer  Year  2000  readiness  plans   will   be
successfully completed in a timely manner.

Year  2000  expenditures were not material  and  were  funded  by
operating   cash  flows.   While  management  does   not   expect
significant disruptions of critical business processes caused  by
internal  Year  2000 issues, the likelihood of  externally-caused
disruptions and the ability of the contingency plans to  minimize
the effects of any such disruptions is not determinable. However,
the  Company believes its Year 2000 remediation efforts, together
with  the  diverse  nature  of its businesses,  help  reduce  the
potential impact of the Year 2000 to levels that will not have  a
material  adverse  impact on its financial position,  results  of
operations, or cash flows.

FORWARD-LOOKING STATEMENTS

This report on Form 10-Q contains statements which, to the extent
they are not statements of historical or present fact, constitute
"forward-looking  statements" under the  securities  laws.   From
time to time, oral or written forward-looking statements may also
be  included  in other materials released to the  public.   These
forward-looking  statements are intended to provide  management's
current  expectations  or  plans for  the  future  operating  and
financial  performance  of  the  Company,  based  on  assumptions
currently  believed to be valid.  Forward-looking statements  can
be  identified  by the use of words such as "believe,"  "expect,"
"plans,"    "strategy,"   "prospects,"   "estimate,"   "project,"
"anticipate,"  and other words of similar meaning  in  connection
with  a  discussion of future operating or financial performance.
These include, among others, statements relating to:

-    the  effect  of  economic downturns or growth in  particular
     regions,
-    the effect of changes in the level of activity in particular
     industries or markets,
-    the anticipated uses of cash,
-    the scope or nature of acquisition activity,
-    prospective product developments,
-    cost reduction efforts,
-    the outcome of contingencies,
-    the impact of Year 2000 conversion efforts, and
-    the transition to the use of the euro as a currency.

<PAGE 16>

All  forward-looking statements involve risks  and  uncertainties
that  may  cause actual results to differ materially  from  those
expressed  or  implied  in the forward-looking  statements.   For
additional information identifying factors that may cause  actual
results  to  vary  materially from those stated in  the  forward-
looking  statements,  see the Company's reports  on  Forms  10-K,
10-Q,  and  8-K filed with the Securities and Exchange Commission
from time to time.  The Company's Annual Report on Form 10-K  for
fiscal  year  1999  includes important  information  as  to  risk
factors  in  the "Business" section under the headings "Operating
Segments"  and  "Other  Matters  Relating  to  the  Corporation's
Business as a Whole."


<PAGE 17>

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES
         ABOUT MARKET RISK

No  material  changes  have  occurred  in  the  quantitative  and
qualitative  market risk disclosures for the Company  from  those
presented  in  the Company's Annual Report on Form 10-K  for  the
year ended April 30, 1999.


<PAGE 18>


                   PART II - OTHER INFORMATION


ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

(a)  Exhibits

     (10.1)*     Change  in Control Agreement, dated  July  14,
                 1999,  between  the  Company  and  Michael  J.
                 Cheshire.
     (10.2)*     Form  of  Change  in Control Agreement,  dated
                 July  14,  1999, between the Company  and  its
                 Senior  Vice Presidents including  Fredric  K.
                 Rosen,  Charles M. Hevenor, Gary  K.  Bennett,
                 and Richard F. Treacy, Jr.
     (10.3)*     Form  of  Change  of Control Agreement,  dated
                 July  14,  1999, between each of the Company's
                 three    domestic   subsidiaries   and   their
                 respective  Presidents  including  Fredric  K.
                 Rosen and Charles M. Hevenor.
     (10.4)*     Change  in Control Agreement, dated  July  14,
                 1999, between the Company and David J. Gerber.
     (10.5)*     Severance Policy for Senior Officers of Gerber
                 Scientific,    Inc.    and    its     domestic
                 subsidiaries.
     (10.6)*     Consulting  Agreement between the Company  and
                 David J. Logan commencing August 10, 1999.
     (10.7)      Gerber  Scientific,  Inc. 2000-2004  Executive
                 Annual Incentive Bonus Plan.
     (15)*       Letter  regarding unaudited interim  financial
                 information.
     (27)*       Financial data schedule.


(b)  Reports on Form 8-K

     No  Form  8-K  was filed during the quarter for  which  this
     report is filed.



*Filed herewith.

<PAGE 19>

                            SIGNATURE


Pursuant  to the requirements of the Securities Exchange  Act  of
1934, the Registrant has duly caused this report to be signed  on
its behalf by the undersigned, thereunto duly authorized.




                               GERBER SCIENTIFIC, INC.
                              ------------------------
                                    (Registrant)




Date:   September 7, 1999   By:  / s / Gary K. Bennett
        ------------------       --------------------------------
                                 Gary K. Bennett
                                 Senior Vice President, Finance
                                 (Principal Financial and
                                 Accounting Officer)
<PAGE 20>

                          EXHIBIT INDEX




  Exhibit
   Index                                                     Page
  Number                                                     ----
 --------

  (10.1)*      Change in Control Agreement, dated July  14,
               1999,  between  the Company and  Michael  J.
               Cheshire.
  (10.2)*      Form  of Change in Control Agreement,  dated
               July  14, 1999, between the Company and  its
               Senior Vice Presidents including Fredric  K.
               Rosen,  Charles M. Hevenor, Gary K. Bennett,
               and Richard F. Treacy, Jr.
  (10.3)*      Form  of Change of Control Agreement,  dated
               July 14, 1999, between each of the Company's
               three   domestic  subsidiaries   and   their
               respective  Presidents including Fredric  K.
               Rosen and Charles M. Hevenor.
  (10.4)*      Change in Control Agreement, dated July  14,
               1999,  between  the  Company  and  David  J.
               Gerber.
  (10.5)*      Severance  Policy  for  Senior  Officers  of
               Gerber  Scientific, Inc.  and  its  domestic
               subsidiaries.
  (10.6)*      Consulting Agreement between the Company and
               David J. Logan commencing August 10, 1999.
  (10.7)       Gerber  Scientific, Inc. 2000-2004 Executive
               Annual  Incentive  Bonus Plan  (incorporated
               herein  by reference to Appendix  A  to  the
               Company's  Definitive Proxy Statement  filed
               in  connection  with the Annual  Meeting  of
               Shareholders to be held September 15,  1999,
               File No. 1-5865).
   (15)*       Letter regarding unaudited interim financial
               information.
   (27)*       Financial data schedule.






*Filed herewith.